CureVac and Novartis in COVID-19 vaccine manufacturing deal
CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s mRNA based COVID-19 vaccine candidate, CVnCoV.
Archives for March 4, 2021
EU rolling review of Russia’s Sputnik V COVID-19 vaccine gets underway
The European Medicines Agency (EMA) has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.
Pharmaron takes UK biologics plant off AbbVie's hands
China's Pharmaron has entered into a definitive agreement to acquire the Allergan Biologics Limited (ABL) site in Liverpool, UK, for US$118.7m in cash from AbbVie.
Allogeneic cell therapy player Century raises $160m in funds to advance pre-clinical pipeline
Century Therapeutics has announced the closing of a US$160m Series C financing round.